Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
KAJT Biotech AB
AB
Active
Org 5594089293
Roddaregatan 30, 216 11
Limhamn
Business and other management consultancy activities
·
NACE 7020
Est. 2022 · 3 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Business and other management consultancy activities
/
KAJT Biotech AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
Revenue
44
122
206
Staff expenses
—
—
—
EBITDA
29
85
198
Depreciation & amort.
—
—
—
EBIT
29
85
198
Net financials
−3
−108
−0
Profit before tax
31
−24
149
Tax
−6
−18
−31
Net profit
25
−41
118
Balance sheet
SEK thousands
Item
2025
2024
2023
Total assets
196
196
261
Equity
127
102
143
Long-term debt
—
—
—
Short-term debt
20
45
68
Total debt
20
45
68
Financial ratios
5-year trend
EBITDA margin
67,1 %
This company
15,8 %
Market median
This company
Market median
325% above market
2023
2025
Equity ratio
64,5 %
This company
38,2 %
Market median
This company
Market median
69% above market
2023
2025
Return on equity
19,8 %
This company
18,4 %
Market median
This company
Market median
8% above market
2023
2025
Net profit margin
57,6 %
This company
8,1 %
Market median
This company
Market median
611% above market
2023
2025
Asset turnover
0,22×
This company
1,12×
Market median
This company
Market median
80% below market
2023
2025
Debt / equity
0,55×
This company
0,62×
Market median
This company
Market median
11% below market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-11-30 – 2023-09-30
View
PDF
More on KAJT Biotech AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
